Evidence map›Paper›PMID 29540663›Full record

ArticleCell death & disease2018

miR-381-3p knockdown improves intestinal epithelial proliferation and barrier function after intestinal ischemia/reperfusion injury by targeting nurr1.

Liwei Liu, Jihong Yao, Zhenlu Li, Guo Zu, Dongcheng Feng, Yang Li, Wasim Qasim, Su Zhang, Tong Li, Huizhi Zeng and 1 more

Abstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Restoration of Hepatic and Intestinal Integrity byMolecules (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liwei LiuDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Jihong YaoDepartment of Pharmacology, Dalian Medical University, Dalian, 116044, China. yaojihong65@hotmail.com.
Zhenlu LiDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Guo ZuDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Dongcheng FengDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Yang LiDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Wasim QasimDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Su ZhangDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Tong LiDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Huizhi ZengDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Xiaofeng TianDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China. txfdl@dmu.edu.cn.ORCID 0000-0002-6654-2270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impairment in gut barrier function induced by intestinal ischemia/reperfusion (I/R) injury is associated with high morbidity and mortality. Intestinal barrier function requires the tight coordination of epithelial migration, proliferation and differentiation. We previously observed that nuclear receptor-related protein 1 (nurr1)-mediated proliferative pathway was impaired in intestinal I/R injury. Here, we aimed to assess the effect of nurr1 on intestinal barrier function and to evaluate microRNA (miRNA)-nurr1-mediated restoration of intestinal barrier function in intestinal I/R injury. We induced an in vivo intestinal I/R injury mouse model by clamping and then releasing the superior mesenteric artery. We also performed an in vitro study in which we exposed Caco-2 and IEC-6 cells to hypoxia/reoxygenation (H/R) conditions to stimulate intestinal I/R injury. Our results demonstrated that nurr1 regulated intestinal epithelial development and barrier function after intestinal I/R injury. miR-381-3p, which directly suppressed nurr1 translation, was identified by microarray and bioinformatics analysis. miR-381-3p inhibition enhanced intestinal epithelial proliferation and barrier function in vitro and in vivo and also attenuated remote organ injury and improved survival. Importantly, nurr1 played an indispensable role in the protective effect of miR-381-3p inhibition. Collectively, these findings show that miR-381-3p inhibition mitigates intestinal I/R injury by enhancing nurr1-mediated intestinal epithelial proliferation and barrier function. This discovery may lead to the development of therapeutic interventions for intestinal I/R injury.

Indexed as

AnimalsCaco-2 CellsCell ProliferationGene Knockdown TechniquesHumansIntestinal MucosaMaleMiceMice, Inbred C57BLMicroRNAsNuclear Receptor Subfamily 4, Group A, Member 2Reperfusion InjuryMicroRNAsMIRN381 microRNA, humanMIRN381 microRNA, mouseNR4A2 protein, humanNr4a2 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 2

Identifiers

PMID29540663
PMCPMC5852084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.